SCHEMBL21744243

SCHEMBL21744243

c1cncc(C2CC2c2ccc3ncccc3c2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.49
POLB P06746 2/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
ALDH1A1 P00352 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
KDM4E B2RXH2 1/20 0.42
TP53 P04637 1/20 0.42
HSP90AA1 P07900 1/20 0.42
HSP90AB1 P08238 1/20 0.42
MAPT P10636 1/20 0.42
TSHR P16473 1/20 0.42
CASP1 P29466 1/20 0.42
HTT P42858 1/20 0.42
ATM Q13315 1/20 0.42
HSD17B10 Q99714 1/20 0.42
MAPK1 P28482 1/20 0.42
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41
SLC6A3 Q01959 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31596870 0.77 POLB (0.49) POLBNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL30945553 0.75 ALDH1A1 (0.45) POLBNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL25005441 0.73 SLC6A4 (0.49) POLBNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL15780114 0.73 SLC6A4 (0.49) POLBNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL22335036 0.73 ALDH1A1 (0.49) POLBNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL28286305 0.73 IDO1 (0.57) POLBNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL29940279 0.73 IDO1 (0.57) POLBNPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL3585897 0.72 FFAR1 (0.46) POLBNPC1RAB9AMAPTHTT
SCHEMBL12049549 0.72 FFAR1 (0.46) POLBNPC1RAB9AMAPTHTT
SCHEMBL31596865 0.72 POLB (0.44) POLBNPC1RAB9AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230112832-A1 Chemokine CXCR4 Receptor Modulators and Uses Related Thereto UNIV EMORY (US) 2023-04-13 US disclosed
US-20200054623-A1 Chemokine CXCR4 Receptor Modulators and Uses Related Thereto EMORY UNIVERSITY 2020-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200054623-A1 Chemokine CXCR4 Receptor Modulators and Uses Related Thereto CXCR4, CXCL12, CXCR1 CYP2A6 4291/4885POLB 3104/4885NPC1 1481/4885
US-20230112832-A1 Chemokine CXCR4 Receptor Modulators and Uses Related Thereto CXCR4, CXCL12, CXCR1 CYP2A6 4291/4885POLB 3104/4885NPC1 1481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.